Primary peritoneal cancer is a type of cancer that starts growing in the peritoneum and sometimes spreads to other organs in the abdomen. These cancers, if confined to the peritoneal cavity are sometimes treated with HIPEC (Hyperthermic Intraperitoneal Chemotherapy), following cytoreductive surgery. Cytoreductive surgery is usually performed by the surgeon first to remove all visible tumours.
HIPEC is delivered directly to the peritoneum after CRS to kill any remaining cancer cells which can increase local drug concentrations, as well as reduce the total systemic exposure from the chemotherapy.
For further information and to find help and support from other people who can understand what you are going through please follow the links at the bottom of this page.
This is not a comprehensive list, If you are a charity or patient group supporting patient affected by these types of cancers please do get it touch so we can link to your organisation.
Cancers Treated with HIPEC or under evaluation for HIPEC include:
Colon and Rectal Cancer, (sometimes referred to as Bowel Cancer)
Colorectal cancer (CRC) is the 3rd most common cancer worldwide1.
Unfortunately, many cases are diagnosed at a late stage, in the UK, 52-56%, and around 23- 26% of those patients have metastases at diagnosis2.
Data presented at the European Society of Medical Oncology (ESMO) 2020 showed approximately 5% of patients with CRC will present with peritoneal carcinomatosis3.
To find out more about the use of HIPEC in the treatment of colo-rectal or bowel cancer please speak with your medical professional.
Ovarian Cancer
Ovarian Cancer is the 8th most commonly occurring cancer in women and the 18th most common cancer worldwide. To find out more about the use of HIPEC in the treatment of ovarian cancer please speak with your medical professional1.
Gastric/Stomach Cancer
Gastric or stomach cancer is the fourth most commonly occuring cancer in men and the seventh most commonly occuring cancer in women. To find out more about the use of HIPEC in the treatment of gastric and stomach cancer please speak with your medical professional1.
Pancreatic Cancer
Pancreatic Cancer is the 12th most common cancer worldwide. To find out more about the use of HIPEC in the treatment of pancreatic cancer please speak with your medical professional.
Pseudomyxoma Peritonei Cancer
Pseudomyxoma Peritonei is a rare form of cancer. To find out more about the use of HIPEC in the treatment of Pseudomyxoma Peritonei please speak with your medical professional.
Peritoneal Mesothelelioma
Peritoneal Mesothelioma is a rare form of cancer. To find out more about the use of HIPEC in the treatment of ovarian cancer please speak with your medical professional.
What is HIPEC Treatment?
HIPEC (Hyperthermic Intraperitoneal chemotherapy). Heated chemotherapy is administered directly to the abdominal cavity following cytoreductive surgery to remove all visible tumours. It has traditionally been administered and recirculated via both open and closed methods. The Combat PRS uses an automatic agitation system to ensure a homogenous drug and thermal distribution througout the abdominal cavity.
*Source: 1 www.wcrf.org – world cancer research fund 2 – www.cancerresearchUK.org/ cancer statistics
3 – www.enewsplanet.com crc-with-peritoneal metastates